Biopharmaceutical Engineering at Queen's University Belfast - UCAS

Queen's University Belfast

Degree level: Postgraduate
Awarded by: Queen’s University Belfast

Biopharmaceutical Engineering (Taught)

Course options

There are other course options available which may have a different vacancy status or entry requirements – view the full list of options

Course summary

Biopharmaceutical products are highly important in today’s global healthcare systems in treating illnesses and disease. The industry in the British Isles has seen significant investment, particularly in the Republic of Ireland (RoI) where there has been capital investment of approximately £7.97 billion in new facilities, mostly in the last 10 years. The global market for biopharmaceuticals was valued at £149 billion in 2017, and is projected to reach £419 billion by 2025, growing at an annual rate of 13.8% from 2018 to 2025. As a result, over 30,000 highly skilled people are currently employed in Ireland north and south with new companies setting up facilities in RoI every year. The increased uptake of skilled biopharmaceutical employees has necessitated the need for a high quality education in this sector. Queen’s University Belfast School of Chemistry and Chemical Engineering has a proven track record for delivering high quality teaching and research and has launched the MSc in Biopharmaceutical Engineering from this platform. This programme will provide students with the knowledge and skills required to work in the field of biopharmaceutical production, separation and purification by applying fundamental science and engineering principles. Through studying this postgraduate taught MSc, graduates will be able to gain a highly relevant qualification which will give them employability on an international level. Through the use of theory and mathematical approaches to engineering problems, students will understand and become skilled in the development of systems which can facilitate biopharmaceuticals production and their subsequent purification. This course is run in collaboration with our industrial partner Eli Lilly, a global company with excellent standing in the field of pharmaceutical and biopharmaceutical production and commercialisation. A collaborative course of this nature is the first of its kind in the British Isles and will provide students with real-world knowledge of how these systems are operated in an industrial setting through the case studies and first-hand knowledge imparted by the academics and industry staff delivering the course.


How to apply

International applicants

Evidence of an IELTS* score of 6.0, with not less than 5.5 in any component, or an equivalent qualification acceptable to the University is required. *Taken within the last 2 years. International students wishing to apply to Queen's University Belfast (and for whom English is not their first language), must be able to demonstrate their proficiency in English in order to benefit fully from their course of study or research. Non-EEA nationals must also satisfy UK Visas and Immigration (UKVI) immigration requirements for English language for visa purposes.

Entry requirements

Normally a 2.2 Honours degree or equivalent qualification acceptable to the University in Chemical Engineering, Chemistry, Pharmacy, Biochemistry or closely allied subject. Applicants with relevant work experience will be considered on a case-by-case basis. The University's Recognition of Prior Learning Policy provides guidance on the assessment of experiential learning (RPEL). Please visit for more information.

Fees and funding

Tuition fees

No fee information has been provided for this course

Additional fee information

For tuition fee information relating to this course please see the University's Postgraduate Tuition Fee website -

Sponsorship information

For more information on funding and scholarships for Postgraduate study, please see

Biopharmaceutical Engineering at Queen's University Belfast - UCAS